» Articles » PMID: 35653121

Potential Mechanisms of Intraocular Pressure Reduction by Micropulse Transscleral Cyclophotocoagulation in Rabbit Eyes

Overview
Specialty Ophthalmology
Date 2022 Jun 2
PMID 35653121
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the histological changes associated with, and the potential mechanisms of, intraocular pressure (IOP) reduction by micropulse cyclophotocoagulation (MP-CPC) in rabbit eyes.

Methods: MP-CPC was performed on the right eyes of Dutch belted rabbits, whereas the left eyes served as controls. The laser power settings were 250, 500, 750, 1000, 1500, and 2000 mW, 10 seconds per sweep, 100 seconds in total. IOP, outflow facility, and uveoscleral outflow tract imaging, using a fluorescent tracer, were examined at one week after MP-CPC. Changes of morphology and protein expressions in the outflow tissues, conjunctiva, and sclera were also evaluated.

Results: Significant reductions in IOP after MP-CPC were observed at 500 to 1000 mW (P = 0.036 and P = 0.014, respectively). The pre-MP-CPC IOP was 11.35 ± 0.41 mm Hg. At one week after surgery, the respective IOP values in the eyes treated at 500 mW and 1000 mW were 9.45 ± 0.49 mm Hg and 7.4 ± 0.27 mm Hg, respectively. Severe ciliary body damage was observed at 1500 to 2000 mW. MMP1-3 and fibronectin expression levels in the outflow tract and ciliary body were upregulated after MP-CPC. The α-smooth muscle actin (α-SMA) was upregulated at higher power levels. MP-CPC significantly increased uveoscleral outflow, whereas the outflow facility did not change. The α-SMA, collagen, and fibronectin were significantly upregulated in the subconjunctiva and sclera.

Conclusions: Reactive fibrotic responses were observed in the outflow tract, conjunctiva, and sclera after MP-CPC. A potential mechanism of IOP reduction by MP-CPC in pigmented rabbit eyes may involve increased uveoscleral outflow related to MMP upregulation.

Citing Articles

Uveoscleral Outflow Routes after MicroPulse Laser Therapy for Refractory Glaucoma: An Optical Coherence Tomography Study of the Sclera.

Agnifili L, Palamini A, Brescia L, Porreca A, Oddone F, Tanga L Int J Mol Sci. 2024; 25(11).

PMID: 38892100 PMC: 11172512. DOI: 10.3390/ijms25115913.


A MEK inhibitor arrests the cell cycle of human conjunctival fibroblasts and improves the outcome of glaucoma filtration surgery.

Lee J, Honjo M, Aihara M Sci Rep. 2024; 14(1):1871.

PMID: 38253821 PMC: 10803501. DOI: 10.1038/s41598-024-52359-y.


The efficacy and safety of micropulse transscleral laser treatment in glaucoma: a systematic review and meta-analysis.

Ling Q, Cai Z, Zhang X, Duan X BMC Ophthalmol. 2023; 23(1):263.

PMID: 37308944 PMC: 10259047. DOI: 10.1186/s12886-023-03017-w.


Efficacy and safety of high-intensity focused ultrasound cyclo-plasty in glaucoma.

Chen D, Guo X, Luo S, Lu Y, Tang X BMC Ophthalmol. 2022; 22(1):401.

PMID: 36207670 PMC: 9542456. DOI: 10.1186/s12886-022-02622-5.

References
1.
Aihara M . Prostanoid receptor agonists for glaucoma treatment. Jpn J Ophthalmol. 2021; 65(5):581-590. DOI: 10.1007/s10384-021-00844-6. View

2.
Tan N, Ang M, Chan A, Barathi V, Tham C, Barton K . Transscleral cyclophotocoagulation and its histological effects on the conjunctiva. Sci Rep. 2019; 9(1):18703. PMC: 6904490. DOI: 10.1038/s41598-019-55102-0. View

3.
Igarashi N, Honjo M, Aihara M . Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy. Exp Eye Res. 2020; 203:108421. DOI: 10.1016/j.exer.2020.108421. View

4.
Klink T, Rauch N, Klink J, Grehn F . Influence of conjunctival suture removal on the outcome of trabeculectomy. Ophthalmologica. 2008; 223(2):116-23. DOI: 10.1159/000181150. View

5.
Johnson M, McLaren J, Overby D . Unconventional aqueous humor outflow: A review. Exp Eye Res. 2016; 158:94-111. PMC: 4970980. DOI: 10.1016/j.exer.2016.01.017. View